Brief: Activist Elliott Investment Management Has Built A Sizable Stake In Bio-Rad Laboratories- WSJ
May 17 (Reuters) - ACTIVIST ELLIOTT INVESTMENT MANAGEMENT HAS BUILT A SIZABLE STAKE IN BIO-RAD LABORATORIES- WSJ ELLIOTT IS ALSO A LARGE INVESTOR IN SARTORIUS, THE GERMAN SUPPLIER OF PHARMACEUTICAL EQUIPMENT THAT BIO-RAD HAS A STRATEGIC INVESTMENT IN- WSJ Source https://tinyurl.com/mfxxancp ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bio-Rad Laboratories
See all newsUS RESEARCH ROUNDUP-Cencora, Dave, Uber
Bio-Rad Laboratories, Inc. reports results for the quarter ended September 30 - Earnings Summary
Bio-Rad's Q3 revenue comes slightly above estimates on Clinical Diagnostics growth
Brief: Bio-Rad Q3 EBIT Margin -7.6%
Bio-Rad Laboratories, Inc. reports results for the quarter ended June 30 - Earnings Summary